glutathione liver disease bile What is and why must we protect patient access to it? Frontiers | Glutathione: Pharmacological aspects
Description
Table 3 Clinical trials of glutaminase inhibitor CB-839 (Telaglenastat) against various types of cancers
Addition of GSH to BSO-treated worms, however, restored the MMP (Fig
Int J Mol Sci 17(7):959
, Hawinkels K., and Keszthelyi D
